1. Home
  2. STKH vs LABT Comparison

STKH vs LABT Comparison

Compare STKH & LABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

HOLD

Current Price

$0.39

Market Cap

566.1K

ML Signal

HOLD

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

HOLD

Current Price

$0.58

Market Cap

473.9K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKH
LABT
Founded
2018
2006
Country
Israel
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
566.1K
473.9K
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
STKH
LABT
Price
$0.39
$0.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $7.50
AVG Volume (30 Days)
229.0K
★ 725.0K
Earning Date
08-25-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$218.44
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.17
52 Week High
$7.10
$6.85

Technical Indicators

Market Signals
Indicator
STKH
LABT
Relative Strength Index (RSI) 26.17 17.47
Support Level $0.33 N/A
Resistance Level $0.64 $2.13
Average True Range (ATR) 0.06 0.05
MACD 0.06 0.02
Stochastic Oscillator 34.33 4.56

Price Performance

Historical Comparison
STKH
LABT

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industry through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures, such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Share on Social Networks: